1. A review of low-density lipoprotein cholesterol, treatment strategies, and its impact on cardiovascular disease morbidity and mortality 
Rishi K. Wadhera, MD, MPhil, Dylan L. Steen, MD, MS, Irfan Khan, PhD, Robert P. Giugliano, MD, SM, JoAnne M. Foody, MD, FACC, FAHA 
Journal of Clinical Lipidology 
Volume 10, Issue 3, Pages (May 2016)
DOI: /j.jacl
Copyright © 2015 National Lipid Association Terms and Conditions

2. Figure 1
Association between absolute change in LDL-C levels over lifetime due to genetic variation and the change in relative risk for CHD.
Based on data from Willer et al., 2008,27 Myocardial Infarction Genetics Consortium et al., 2014,29 Linsel-Nitschke et al., 2008,30 Cohen et al., 2006,33 Ference et al., 2012,34 and Stender et al., The figure has been limited to data from these studies regarding mutations with significant associations with both LDL-C levels and coronary outcomes. The studies were reviewed for duplicate reporting of data. Labels in the graph represent genes; repeated observations (e.g. LDLR) represent different SNPs. Where OR or HR were reported, change in relative risk was approximated as OR – 1 or HR – 1. The solid line represents estimated relationship via linear unweighted regression (Y =  × X + 0.0173).
CHD, coronary heart disease; HR, hazard ratio; LDL-C, low-density lipoprotein cholesterol; OR, odds ratio; SNP, single-nucleotide polymorphism.
Journal of Clinical Lipidology  , DOI: ( /j.jacl )
Copyright © 2015 National Lipid Association Terms and Conditions